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Abstract
Optogenetic techniques have given researchers unprecedented access to the function of discrete 
neural circuit elements and have been instrumental in the identification of novel brain pathways 
that become dysregulated in neuropsychiatric diseases. For example, stress is integrally linked to 
the manifestation and pathophysiology of neuropsychiatric illness, including anxiety, addiction 
and depression. Due to the heterogeneous populations of genetically and neurochemically distinct 
neurons in areas such as the bed nucleus of the stria terminalis (BNST), as well as their substantial 
number of projections, our understanding of how neural circuits become disturbed after stress has 
been limited. Using optogenetic tools, we are now able to selectively isolate distinct neural circuits 
that contribute to these disorders and perturb these circuits in vivo, which in turn may lead to the 
normalization of maladaptive behavior. This review will focus on current optogenetic strategies to 
identify, manipulate, and record from discrete neural circuit elements in vivo as well as highlight 
recent optogenetic studies that have been utilized to parcel out BNST function.
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Stress is defined as the body’s response to any demands for change1. Although stress can be 
positive, as it forces an organism to adapt in order to survive, the neurophysiological 
components of the stress response often times become disturbed in neuropsychiatric 
illnesses, such as depression, generalized anxiety disorder, post traumatic stress disorder and 
drug and alcohol addiction2345. Thus, in order to develop novel and effective treatments, a 
critical understanding of how discrete neural circuit elements are altered through stress-
producing stimuli is essential.
The extended amygdala has been implicated in rodent and human studies as a crucial 
mediator of the behavioral effects of aversive stimuli and both acute and chronic 
stress678910. The region is comprised of the bed nucleus of the stria terminalis (BNST), the 
central (CeA) and medial (MeA) nucleus of the amygdala, and the shell of the nucleus 
accumbens (NAc)11. Since the extended amygdala encapsulates many different structures 
and cell types, which are intermingled within these regions, the neurophysiological 
properties and behavioral importance of genetically distinct neural circuits mediating stress 
and anxiety remain elusive. This review will focus on current optogenetic strategies that can 
be used to examine neural circuit function from synapse to behavior. In addition, this review 
will also highlight recent optogenetic strategies that have been used to dissect the BNST, a 
region that has been implicated in the integration and processing of the stress response10.
Optogenetics
Introduction of the light-gated cation channel channelrhdopsin-2 (ChR2) or chloride and 
proton pumps such as halorhodpson (NpHR) and archaerhodopsin (Arch) into genetically 
defined neural tissues has revolutionized neuroscience12131415. Opsin proteins can be 
delivered into mammalian brain tissue through viral vectors that contain cell specific 
promoters, such as calcium-calmodulin dependent protein kinase IIα (CaMKIIα)161718. 
Additionally, transgenic animals that express cre-recombinase in defined populations of 
neurons can be injected with viral vectors encoding a cre-inducible opsin protein, to express 
opsins in only neurons that contain cre-recombinase192021. This approach has been used to 
target discrete neuronal subtypes in the ventral tegmental area (VTA). For example, infusion 
of a cre-inducible ChR2 into the VTA of Vgat-cre mice transduced only GABAergic 
neurons21. Thus, promoter driven and cre-dependent viral strategies allow for the precise 
control of neurochemically discrete cell bodies and terminals in heterogeneous brain tissue. 
Unlike other neuroscience approaches such as lesions and pharmacology, optogenetics 
allows for more temporally controlled perturbations of distinct neural circuit pathways in 
awake and behaving animals. Furthermore, the combination of optogenetic strategies and 
traditional pharmacological techniques can also increase the precision of neural circuit 
manipulations22. Importantly, optogenetic techniques can be utilized for long term 
behavioral manipulations, which is critical for identifying novel neural circuits that are 
involved in chronic stress. For a more thorough review of optogenetic procedures and 
principles see23142224. This review will now focus on several new strategies that utilize 
optogenetic techniques to assist in the identification and modulation of discrete neural 
circuits in brain slices and behaving animals.
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ChR2-assisted circuit mapping allows for the characterization of functional connectivity 
between multiple neural substrates in heterogeneous tissue. With ChR2-assisted circuit 
mapping, axons and terminals from an input brain region can be optically stimulated even 
when excised from cell bodies, thus allowing for the examination of circuit connectivity in 
brain slices. In one of the first studies to utilize this procedure, Petreanu et al.25 transduced 
pyramidal neurons in layers 2/3 of the somatosensory cortex with ChR2. Presynaptic 
terminals from this region were then optically stimulated in various cortical output areas to 
examine their synaptic input onto targeted postsynaptic neurons using slice 
electrophysiology. In these experiments, the authors found that layers 2/3 pyramidal neurons 
synapse onto pyramidal neurons in layers 2/3/5/6, a finding that would have been difficult to 
obtain using traditional electrophysiological techniques. In an elegant series of experiments, 
Atasoy et al.19, used ChR2-assisted circuit mapping to functionally dissect subcircuits 
within the arcuate nucleus of the hypothalamus (ARC) and their projection neurons in order 
to deconstruct neural circuits that control hunger and feeding. Initially, the authors 
transduced two populations of neurons: agouti-related peptide (AGRP)- and pro-
opiomelanocortin (POMC)-containing cells, within the ARC with a cre-inducible ChR2 to 
test their functional connectivity. Using optogenetics in conjunction with patch-clamp 
electrophysiology, the authors demonstrated that AGRP-containing neurons formed 
functional synapses on POMC-containing neurons within the ARC and that optical 
stimulation of the ARCAGRP-ARCPOMC circuit produced robust inhibitory post-synaptic 
currents. Furthermore, no synaptic responses were seen in ARCAGRP-ARCAGRP, 
ARCPOMC-ARCAGRP, or ARCPOMC-ARCPOMC circuits. Additionally, the authors 
examined the behavioral consequences of stimulating AGRP-containing ARC neurons on 
two output areas: the paraventricular nucleus of the hypothalamus (PVH) and the 
parabrachial nucleus (PBN). In these studies, AGRP neurons were transduced with a cre-
inducible ChR2 with optical fibers implanted above the PVH and PBN within the same 
animal. Optical stimulation of the ARCAGRP-PVH pathway produced robust increases in 
food intake, whereas optogenetic activation of the ARCAGRP-PBN pathway had no effect.
Although the previous studies examined the functional connectivity of neural circuit output 
regions, optogenetic techniques can also be used to examine synaptic input onto a brain 
region of interest. For example, viral vectors such as rabies, which allow for the retrograde 
transport of proteins, can be employed26. Watabe-Uchida et al.,27 used an EnvA-
pseudotyoed, G-deleted rabies virus to visualize monosynaptic inputs to genetically defined 
neurons within the VTA in an exquisite series of experiments. In these studies, an AAV 
coding a cre-inducible avian receptor TVA, required for initial infection, and an AAV 
encoding rabies virus envelop glycoprotein (RG), necessary for transsynaptic spread, was 
injected into the VTA or substantia nigra reticulata (SNr) in dopamine transporter (DAT) -
cre mice, to transduce only dopaminergic neurons expressing TVA. Approximately 2 weeks 
after the initial viral cocktail injection, the same mice were injected with the modified rabies 
virus. Since only neurons that expressed TVA were transduced by the rabies viral construct, 
inputs to dopamine neurons were visualized and quantified, providing a comprehensive map 
of midbrain dopaminergic circuitry. Furthermore, rabies viral vectors can also be packaged 
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with cre and used in combination with optogenetic strategies in order to selectively control 
presynaptic inputs into a target region. Utilizing these techniques, Chaudhury et al.28, 
injected a pseudorabies virus expressing cre (PRV-cre) into the NAc and an AAV coding a 
cre-inducible ChR2 into the VTA. Consequently, only neurons that expressed cre expressed 
a functional ChR2. Thus, the authors were able to optically stimulate VTA neurons that 
project to the NAC to manipulate behavior during a social-interaction task. Opsins can also 
be tethered to rabies viral vectors for trans-synaptic transduction. Lammel et al.29 injected a 
rabies virus coding a cre-inducible ChR2 into the VTA of tyrosine hydroxylase (TH) -cre 
mice and implanted fibers into two VTA input structures, the laterodorsal tegmentum (LDT) 
and the lateral habenula (LHb). Due to the retrograde insertion of ChR2, the authors were 
able to control two distinct inputs onto VTA dopamine neurons. The authors found that 
optical stimulation of the LDT caused a conditioned place preference, whereas optogenetic 
activation of the LHb resulted in a conditioned place aversion, consistent with previous 
data30. One caveat in using a rabies viral vector for retrograde transsynaptic labeling, 
however, is that the virus will cause cell death approximately 2 weeks post transduction26. 
Thus, long-term behavioral manipulations are often not feasible. Herpes simplex viral 
vectors (HSV), which can also retrogradely transport proteins, such as opsins, may be 
beneficial for long term in vivo applications since cell death from viral infection is 
significantly lowered when compared to rabies. Additionally, HSV allows for rapid 
transduction (approx. 24 hr) into cell bodies, whereas AAV vectors take approximately 10–
14 days for maximal expression. Figure 1 depicts a schematic summary detailing various 
strategies discussed for optogenetic circuit mapping.
Optogenetic manipulation of projection neurons in vivo
Although a majority of optogenetic experiments have focused on controlling cell bodies to 
measure a behavioral phenotype31323334353620, opsins can be trafficked from the soma to 
axon terminals for pathway specific stimulation or inhibition, as mentioned previously in the 
experiments conducted by Atasoy et al19. In another example, Stamatakis et al.30 globally 
transduced lateral habenula (LHb) neurons with ChR2 and implanted a fiber optic above the 
rostromedial tegmental nucleus (RMTg) in order to stimulate the LHb-RMTg pathway 
during behavioral tasks. The authors found that optical stimulation of LHb-RMTg neural 
circuit resulted in active, passive, and conditioned behavioral avoidance, indicating that this 
pathway is aversive. One drawback for stimulating axon terminals in vivo using optogenetic 
manipulations is that ChR2-activation of axon terminals produces back-propagating action 
potentials, thereby activating transduced cell bodies, which in turn can activate axons to 
other brain regions. To minimize the potential contribution of network activity, 
pharmacological inactivation of ChR2-infected cell bodies, in conjunction with optical 
stimulation, during behavioral assays can be employed. In a study by Stuber et al.17, BLA 
glutamatergic efferents were transduced with ChR2 and a guide cannula was placed above 
the NAc for optogenetic activation of the BLA-NAc pathway. In these studies, mice reliably 
nose poked to receive optogenetic stimulation of BLA glutamatergic fibers terminating 
within the NAc. To further test the specificity of the BLA-NAc pathway in promoting 
reward seeking, the authors injected lidocaine into the BLA to inactivate ChR2-expressing 
cell bodies before the start of the nose-poking task. Infusions of lidocaine did not alter the 
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acquisition or expression of reward-seeking behavior, indicating that the effects observed 
were not due to the influence of network mediated activity through the BLA. Another 
limitation of using optogenetic terminal stimulation in vivo is that fibers of passage from the 
transduced brain region may also be activated if they pass through the output target area. 
Therefore, to demonstrate that the behavioral effects of ChR2 terminal stimulation are 
specific to the circuit, and not from fibers of passage, traditional pharmacological 
manipulations can be incorporated with optogenetic strategies. As previously discussed, 
Atasoy et al.,19 optically stimulated inhibitory AGRP fibers originating in the ARC within 
the PVH, which increased food intake. In a separate series of experiments, the authors 
infused a GABA antagonist into the PVN during ARCAGRP-PVN optical stimulation in a 
feeding paradigm. This resulted in a significant reduction of food intake, indicating the 
behavioral necessity of ARCAGRP signaling within the PVN in promoting feeding.
Optogenetic identification of neurons in vivo
By combining optogenetics techniques and in vivo electrophysiology, real-time 
identification and recordings of distinct, genetically identified neurons is possible in 
heterogeneous brain tissue. In a recent study, Cohen et al.37, recorded the activity of 
neurochemically distinct neurons in the VTA using optogenetic strategies in vivo. Here, the 
authors utilized the cre-dependent viral strategy in order to selectively target either 
dopaminergic or GABAergic neurons with ChR2 in DAT-cre and Vgat-cre mice, 
respectively. By coupling a fiber optic to a multielectrode array, which was implanted in the 
VTA, the authors revealed the identity of the recorded neurons using ChR2-mediated 
spiking during a classical conditioning task.
A recent study used a similar optical identification technique in order to identify genetically 
distinct circuit projection neurons. In these studies, Jennings, Sparta et al.38 transduced 
glutamate and GABA neurons with ChR2 in the BNST of Vglut2-cre and Vgat-cre mice, 
respectively. Additionally, a multielectrode array was implanted in the BNST with an 
optical fiber above the VTA. By photostimulating terminals in the VTA, antidromic spiking 
was reliably detected within the BNST based on back propagating action potentials. 
Latencies in spike detection were then utilized to filter possible transsynaptic spikes from 
responses due to antidromic activation. Importantly, these experiments were completed in 
awake and behaving animals, which allowed for the real-time measurement of neuronal 
activity in optically identified VTA-projecting BNST glutamate and GABA during 
behavioral assays.
Strategies for optogenetic manipulation in vivo
Acutely implanted optical fibers were initially used to optogenetically perturb neural circuits 
in vivo. For this procedure, a fiber optic coupled to a laser was inserted into a guide cannula 
before any behavioral manipulations. However, these optical fibers often broke inside the 
cannula and repeated insertion of the optical fiber led to tissue damage. Therefore, the 
development of implantable optical fibers that can manipulate neural circuit elements with 
minimal tissue damage or change in light output over time has optimized optogenetic tools 
with long-term behavioral experimentation. These implanted optical fibers readily interface 
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with in vivo electrophysiological arrays or electrochemical detection electrodes to provide a 
more thorough probing of neural circuits in vivo39. Importantly, implantable optical fibers 
can penetrate into deep brain structures such as the VTA21. Light emitting diodes (LEDs) 
can also be used to deliver light to mammalian tissue. These devices have been used to 
photostimulate neurons transduced with ChR2 in the barrel cortex during a detection task40. 
Recently, wireless LEDs have been developed, which allow for the transmission of light into 
the brain without the need to tether an animal to an optical patch cable41. These devices 
weigh between 2–3 g, allow the animal a full range of movement, and can deliver up to 2 W 
of power. Wentz et al.41 used wireless LEDs to deliver light in vivo to activate ChR2-
transuced neurons within the motor cortex during a locomotor assay. One caveat with LEDs 
is the limited level of depth that light can penetrate into brain tissue. Studies using LEDs for 
optical stimulation in vivo have focused primarily on cortical regions although a recent study 
has utilized an injectable wireless LED in order to perturb deep brain structures such as the 
VTA42. These microLEDs are approximately 1000 × smaller than traditional LEDs and can 
provide better spatial resolution. Additionally, these devices can be coupled with electrode 
arrays that allows for concurrent collection of photostimulation and neuronal spiking from 
the same brain region. This review will now focus on optogenetic strategies used to dissect 
the BNST, an integral structure of the stress response.
BNST
The BNST is considered to be a connective locus between amygdaloid stress regions 
including the BLA and CeA and brain reward centers such as the VTA and 
NAc114344454610. The BNST can be subdivided into many sub-nuclei, including the oval, 
juxtacapsular, and rhomboid nuclei47, yet consists primarily of GABAergic neurons48. 
However, neurons expressing vesicular glutamate transporters (Vglut2 and Vglut3) are also 
evident464950. Neuropeptides including corticotropin releasing factor (CRF), neuropeptide Y 
(NPY), enkephalin, substance P, neurotensin, and dynorphin also comprise many BNST 
neurons5152535455565057. These neuropeptides can be used as selective markers for small 
subpopulations of cells. However, their role is not well-understood in the regulation of the 
stress response.
BNST and stress
The BNST has been implicated in integrating and processing stress as well as pathological 
anxiety states, such as post traumatic stress disorder (PTSD), that result from chronic stress 
exposure and/or aversive stimuli58596061626364. The BNST has been hypothesized to mediate 
“sustained” fear and/or anxiety after repeated stressors, as well as contextual cues that 
predict aversive and/or stressful stimuli65. Information pertaining to acute or phasic fear 
responses, on the other hand, is thought to be mediated by other amygdala nuclei, such as 
the BLA and CeA6664. Additionally, the BNST has been linked as a key structure in 
modulating stress-induced reinstatement of drug seeking67. Inactivation of the BNST, using 
muscimol and baclofen, can block cocaine reinstatement following injections of the 
pharmacological stressor yohimbine68. Interestingly, BNST efferents to brain reward centers 
such as the VTA can encode stressful stimuli, as VTA-projecting BNST neurons exhibit 
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increased c-Fos protein levels following cocaine reinstatement and a forced swim 
stressor6970.
One intriguing signaling molecule within the BNST that plays a key role in modulating 
stress is CRF. Stress-producing stimuli can elevate CRF expression in the dorsolateral and 
ventrolateral regions of the BNST71727374. Additionally, overexpression of CRF by a 
lentivirus in the BNST enhances a conditioned fear response75. Consistent with the BNST’s 
role in promoting sustained fear/anxiety, administration of a CRF antagonist into the BNST 
blocked sustained, but not phasic, fear behaviors65. Moreover, intra-BNST injections of 
CRF antagonists can block both stress-induced reinstatement of cocaine seeking and 
morphine conditioned place preference7677. Interestingly, acute inhibition of the BNST by 
tetrodotoxin (TTX) injection during stress exposure prevents the expression of stress-
induced anxiety58 and activation of CRF receptors directly in the BNST induces social 
anxiety78. In a recent study, Gafford et al.,79 knocked out GABAA α1 subunits in CRF-
containing neurons within in the BNST, causing increases in anxiety-like behavior as well as 
impairments in the extinction of conditioned fear. These behavioral deficits were rescued 
with an intra-BNST infusion of a CRF antagonist.
Since the BNST comprises many different subnuclei and genetically distinct cell types, 
parceling out specific neural circuit elements that are altered during or following stress 
exposure has been extremely challenging. Moreover, little is known about specific BNST 
projection targets since electrical stimulation of this structure often results in indirect 
stimulation of other brain regions and fibers of passage. However, by utilizing optogenetic 
strategies, we now have a contemporary toolkit that will provide a circuit-aided design to 
determine how genetically defined BNST neural circuits process and respond to stress-
producing stimuli.
Optogenetic manipulations of BNST neural circuits
Within the BNST, this type of precise functional circuit mapping described above will be 
essential for dissecting the plethora of genetically distinct neurons and neural circuit 
elements that are involved in the stress response, which traditional anatomical tracing and 
electrophysiology techniques cannot address. Conventional circuit tracing experiments 
cannot differentiate between distinct cell types in heterogeneous tissue. Additionally, 
electrophysiology experiments, which utilize electrical stimulation, do not provide precise 
synaptic connectivity due to stimulation of all cell types as well as fibers of passage. Two 
recent studies have utilized optogenetic strategies to parcel out distinct BNST circuits 
involved in reward, stress, and anxiety-related behaviors. Kim et al.80 globally transduced 
BNST neurons with NpHR in order to inhibit cell bodies within this region. The authors 
demonstrated that photoinhibition of the BNST increased open-arm time in an elevated plus 
maze (EPM), indicative of anxiolysis. Conversely, photostimulation of the BNST with 
ChR2 resulted in anxiogenesis, as mice spent less time in the open arm of the EPM. In the 
same study, the authors then examined the role of BLA inputs into the BNST on anxiety-like 
behaviors. In these experiments, separate groups of mice were injected with a viral vector 
containing either ChR2 or NpHR into the BLA. Additionally, mice were implanted with 
optical fibers above the BNST in order to stimulate or inhibit BLA terminals within the 
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BNST. Surprisingly, the authors found that photostimulation of the BLA-BNST pathway 
produced anxiolysis, whereas photoinhibition of this pathway resulted in anxiogenesis in 
both the EPM and respiration rate. In a final series of experiments, the authors examined the 
behavioral ramifications of stimulating three discrete BNST output regions: LH, VTA, and 
PBN. Here, the authors reported that photostimulation of BNST efferents in each of the 
target output regions resulted in a unique behavioral phenotype of the anxiety-like state. 
Jennings, Sparta et al.38, demonstrated that parallel yet opposing BNST subcircuits modulate 
divergent motivational states by utilizing optogenetic techniques. The authors transduced 
both glutamatergic and GABAergic BNST neurons with ChR2 in Vglut2-cre and Vgat-cre 
mouse lines, respectively. By antidromically stimulating BNST terminals within the VTA, 
the authors were able to identify VTA-projecting BNST glutamate and GABAergic neurons 
during a foot-shock stress paradigm. The authors found that aversive foot shock caused a net 
enhancement of activity of optically identified VTA-projecting BNST glutamate neurons. In 
contrast, aversive foot shock resulted in the reduction of activity in optically identified 
VTA-projecting BNST GABA neurons. In a separate series of experiments, the authors 
found that photostimulation of BNST-VTA glutamatergic fibers resulted in aversion and 
anxiety-like behavior, whereas photostimulation of BNST-VTA GABAergic terminals 
promoted reward-related behaviors and buffered stress induced anxiety. The results from 
both of these studies indicate that the BNST has a more complex role than what is 
canonically thought in regard to stress, anxiety, and reward. Figure 2 depicts a schematic of 
potential BNST output stress neural circuits, which can be manipulated by optogenetic 
strategies discussed above.
Conclusions
Using optogenetic strategies, we now have the ability to parcel out neural circuits within 
heterogeneous structures, such as the BNST, in order to examine their contribution to the 
stress response. With these new techniques, we will come to a greater understanding of 
BNST neural circuits that are recruited during exposure to stressful stimuli and potentially 
identify new pharmacological targets for the treatment of neuropsychiatric illness.
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ARC arcuate nucleus of the hypothalamus
Arch archaerhodopsin
BLA basolateral amygdala
BNST bed nucleus of the stria terminalis
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CaMKIIα calcium-calmodulin dependent protein kinase IIα
CeA central nucleus of the amygdala
ChR2 channelrhodopsin-2
CRF corticotropin releasing factor
DAT dopamine transporter
GABA γ-Aminobutyric acid
HSV herpes simplex virus












PTSD post traumatic stress disorder
PVH paraventricular nucleus of the hypothalamus
RG rabies virus envelop glycoprotein
RMTg rostromedial tegmental nucleus
SNr substantia nigra reticulata
TH tyrosine hydroxylase
TTX tetrodotoxin
TVA avian retroviral receptor
Vgat vesicular GABA transporter
Vglut vesicular glutamate transporters
W watts
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Review of current techniques for optogenetic neural circuit mapping.
Strategies for optogenetic manipulation of neural circuit elements in vivo.
Review of optotgenetic techniques used to dissect the BNST.
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Figure 1. Optogenetic strategies for circuit mapping
a. Schematic detailing how to employ ChR2 assisted circuit mapping in slice 
electrophysiology. Presynaptic neurons are transduced with ChR2-eYFP. Optical 
stimulation (473 nm light to optimally activate ChR2) of transduced presynaptic terminals 
results in the detection of ChR2 mediated currents in the patch clamped postsynaptic neuron. 
Additionally, the recording pipette can be filled with dye to identify its neurochemical 
makeup. b. Schematic detailing how to employ a rabies viral delivery strategy in order to 
manipulate VTA neurons terminating in the NAc. Pseudorabies (PRV) that express a 
functional cre protein is injected into the NAc. PRV-cre is taken up by presynaptic terminals 
in the NAc. Infusion of a cre-inducible ChR2 into the VTA. Only neurons that express cre 
will express ChR2. An optical fiber is implanted above the VTA in order to manipulate 
VTA neurons that project to the NAc.
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Figure 2. Potential BNST stress neural circuits
The BNST sends projections to the VTA, PAG, CeA, PBN, and LH. These potential stress 
neural circuits can be analyzed using optogenetic strategies detailed above.
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